Preclinical evaluation of CDK4/6 inhibitor GLR2007 in glioblastoma models
Lei Yin – Gan & Lee Pharmaceuticals, Beijing, China
Features of treatment of leptomeningeal dissemination for children with rabhomyosarcoma paramenongeal localization with intracranial distribution
Anastasia D. Rodina – Research Center of Oncology, Moscow, Russian Federation
Factors associated with short survival after whole brain radiotherapy for brain metastases in patients with non-small cell lung cancer
Astrid T. Karlsson – Department of Oncology, Oslo University Hospital, Oslo, Norway
Whole brain radiotherapy for melanoma brain metastases – which patients are likely to live ≤3 months after treatment?
Olav E. Yri – Dep of Oncology and European Palliative Care Research Centre (PRC), Oslo University Hospital